home / stock / gmda / gmda news


GMDA News and Press, Gamida Cell Ltd. From 08/01/23

Stock Information

Company Name: Gamida Cell Ltd.
Stock Symbol: GMDA
Market: NASDAQ

Menu

GMDA GMDA Quote GMDA Short GMDA News GMDA Articles GMDA Message Board
Get GMDA Alerts

News, Short Squeeze, Breakout and More Instantly...

GMDA - Gamida Cell to Report Second Quarter 2023 Financial Results

Conference Call and Webcast Scheduled for Monday, August 14 th at 8:30 am Eastern Time Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the second qua...

GMDA - Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell's Omisirge® (omidubicel-onlv)

Faster immune reconstitution and decreased rate of post-transplant viral infection in patients transplanted with Omisirge versus umbilical cord blood Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the publica...

GMDA - STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER

STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER PR Newswire Veteran Oncology Researcher to Guide Investment in Breakthrough Cancer Treatments LOS ANGELES , July 10, 2023 /PRNewswire/ -- Stand Up To Cancer ® (SU2C) ...

GMDA - Catalyst Watch: Fed stress tests, Snowflake event, AMC hearing and Delta guidance

2023-06-23 15:00:37 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

GMDA - Gamida Cell To Host Investor Day

Thought leaders Dr. Steven Devine and Dr. Usama Gergis to share perspectives on unmet needs and the clinical landscape in stem cell transplant Update on the progress of the commercial launch for Omisirge ® to be provided Gamida Cell Ltd. (Nasdaq: GMDA), a cell...

GMDA - Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting

New data for batch-to-batch variability and cytotoxicity of GDA-201 show long term stability and unique phenotype of allogeneic NAM-NK cell therapy GDA-201 is in an ongoing Phase 1/2 clinical trial for non-Hodgkin lymphoma Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pion...

GMDA - Gamida Cell gets new finance chief

2023-05-22 08:29:57 ET Gamida Cell ( NASDAQ: GMDA ) names Terry Coelho as CFO effective immediately. Shai Lankry, who has served as the company’s CFO for the past five years, is stepping down as CFO today and will leave the company June 2. The transition is...

GMDA - Gamida Cell Appoints Terry Coelho as CFO

Industry veteran Coelho brings more than 35 years of experience at emerging growth and global companies to role; Shai Lankry to leave company June 2 Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment ...

GMDA - Gamida Cell Ltd. (GMDA) Q1 2023 Earnings Call Transcript

2023-05-15 20:39:08 ET Gamida Cell Ltd. (GMDA) Q1 2023 Results Conference Call May 15, 2023 04:30 PM ET Company Participants Mike Kuczkowski - Corporate Communications Abbey Jenkins - President and CEO Michele Korfin - COO and Chief Commercial Officer Ronit S...

GMDA - Gamida Cell GAAP EPS of -$0.27 in-line

2023-05-15 16:45:12 ET Gamida Cell press release ( NASDAQ: GMDA ): Q1 GAAP EPS of -$0.27 in-line. 2023 Guidance: As of March 31, 2023, Gamida Cell had total cash and cash equivalents of $46.8 million. This amount does not include the approximately $25 million in net pr...

Previous 10 Next 10